China-developed nasal spray vaccine for COVID-19 approved for clinical trials
CGTN

Translating...

Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.

The University of Hong Kong (HKU) Wednesday announced that the clinical trials of a nasal spray vaccine for COVID-19 jointly developed by the university's Department of Microbiology and mainland institutions has been approved.

The State Key Laboratory of Emerging Infectious Diseases has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.

It is the first nasal spray COVID-19 vaccine approved by the China's National Medical Products Administration for clinical trial in humans.

HKU said in a statement that its vaccine strategy has been selected as one of the five vaccine technologies by the Ministry of Science and Technology for further evaluation.

(Cover: The nasal spray vaccine for COVID-19 jointly developed by the University of Hong Kong, Xiamen University and Beijing Wantai Biological Pharmacy. /Photo via Xiamen University)

Source(s): Xinhua News Agency
TOP NEWS
China outlines tasks to advance rural revitalization in No. 1 document
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

China

09:52, 23-Feb-2025

China slams US investment curbs, vowing to protect its interests
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Economy

03:49, 23-Feb-2025

Germany's CDU/CSU leads federal election: preliminary results
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Europe

23:03, 23-Feb-2025